- Acquisition of US-based Critical Process Systems (CPS) Group from Wynnchurch Capital
- Strengthening of services and process equipment offering
- Growth acceleration through complementary regional footprint and synergies in semiconductor and life science markets
Stuttgart, 02 November 2021 – Group (“Exyte”) has completed the all-share acquisition of US-based Critical Process Systems Group (“CPS”) from Wynnchurch Capital. The transaction enhances Exyte’s global offering for customers in the semiconductor and biopharma and life sciences businesses.
